Posted by Michael Wonder on 03 Nov 2023
ICER publishes third annual assessment of barriers to fair access within US commercial insurance prescription drug coverage
3 November 2023 - While many payers offer fair access across the domains evaluated, findings underscore the need for greater transparency of coverage policy information for patients.
The Institute for Clinical and Economic Review today published its third annual “Barriers to Fair Access” assessment of prescription drug coverage policies within US commercial insurance, and the Veterans Health Administration.
